CVS and McDonald's earnings reports could confirm or challenge their 'too cheap to ignore' status amid market risks.

CVS Health and McDonald's are set to report earnings soon, with both stocks labeled 'too cheap to ignore' by Jim Cramer despite underlying risks. CVS has shown strong earnings growth and raised its full-year guidance, but faces potential policy risks related to Medicare drug reimbursement cuts. McDonald's, trading at its lowest valuation since 2014, needs to demonstrate a recovery in U.S. customer traffic and better execution of its value menu to justify its price. Investors will closely watch these reports to see if these companies can sustain their income stories or if the risks will weigh on their stock prices.

As of Nov 03, 2026 20:13 WIB, CVS Health shares trade at USD 88.34 with a slight 0.19% decline and show strong investor confidence on Pluang with 100% buy orders. McDonald's is priced at USD 262.31, down 1.25% for the day, and sees predominantly sell activity at 93% on Pluang. Notably, CVS offers a dividend yield of 3.01%, highlighting income potential amid earnings scrutiny.